Phase 3 N=1,992 A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine
Haemophilus Influenza
Primary: Number of Participants With Solicited Adverse Reactions — 507; 480 Count of Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=40 Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Non-Hodgkins Lymphoma
Primary: Overall Response Rate — 31 Percentage of participants
Phase 3 N=196 Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Head and Neck Cancer · Xerostomia
Primary: Phase II: Treatment Compliance (Number of Compliant Patients) — 12; 44 Participants
N/A N=30 Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery
Posterior Cervical Surgery · Posterior Cervical Fusion · Posterior Cervical Laminectomy
Primary: Average Neck Pain Level — 1; 1 units on a scale (VAS pain scale)
N/A N=58 Effects and Mechanisms of Specific Trunk Exercises in Low Back Pain
Low Back Pain
Primary: Change From Baseline to 11 Weeks in Oswestry Disability Scale (0-100%) — -11.06; -9.10 units on a scale — p=<.0001
Phase 2 N=19 Immunomodulatory Properties of Ketamine in Sepsis
Sepsis
Primary: Serum Levels of IL-6, IL-10 and TNFα — 28; 16; 9.3; 6.3 pg/mL
N/A N=59 Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
Brain and Central Nervous System Tumors · Long-term Effects Secondary to Cancer Therapy in Children
Primary: Cumulative Incidence of Ototoxicity — 12; 16; 16; 15 percentage of participants
Phase 3 N=840 Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy
Prostate Cancer
Primary: Overall Survival (12-year Rates Reported) — 71.3; 76.3 percentage of participants — p=0.020
Phase 4 N=84 Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder
Borderline Personality Disorder · Suicide
Primary: Suicide Events — 12; 4 suicide events
N/A N=283 Clinical Evaluation of Two Approved Contact Lenses
Visual Acuity
Primary: Overall Comfort — 72.5; 63.8 Units on a Scale
Phase 3 N=30 Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Peripheral Neuropathy · Breast Cancer
Primary: Change in Peripheral Neuropathy Score — 0.3; 0.9 Change in Total Neuropathy Score
N/A N=158 Improving Adherence to Smoking Cessation Medication Among PLWHA
Tobacco Use Cessation
Primary: End-of-intervention Varenicline Adherence — 18; 16; 15 participants
Phase 4 N=199 A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma
Asthma
Primary: Change From Baseline (BL) in Trough Morning Forced Expiratory Volume in One Second (FEV1) at Day (D)29 — 0.194; 0.150 Litre (L)
N/A N=10 Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
Asthma
Primary: Percent Forced Expiratory Volume in One Second (FEV1) — 90; 88 % FEV1
Phase 4 N=181 A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
Malaria
Primary: The Proportion of Adverse and Serious Adverse Events Following Unsupervised Primaquine Treatment — 0; 0; 0 events